Aurobindo Pharma Ltd. Conference Calls and Earnings Call Transcripts

Aurobindo Pharma Ltd. Conference Calls and Earnings Call Transcripts: Get insights into company performance, financials, capex plans, and more.

Quarter
All Jul-Sep 2025 Apr-Jun 2025 Jan-Mar 2025 Oct-Dec 2024 Jul-Sep 2024 Apr-Jun 2024 Jan-Mar 2024 Oct-Dec 2023 Jul-Sep 2023 Apr-Jun 2023 Jan-Mar 2023 Oct-Dec 2022 Jul-Sep 2022 Apr-Jun 2022 Jan-Mar 2022 Oct-Dec 2021 Jul-Sep 2021 Apr-Jun 2021 Jan-Mar 2021 Oct-Dec 2020 Jul-Sep 2020 Apr-Jun 2020 Jan-Mar 2020 Oct-Dec 2019 Jul-Sep 2019 Apr-Jun 2019 Jan-Mar 2019 Oct-Dec 2018 Jul-Sep 2018 Apr-Jun 2018 Jan-Mar 2018 Oct-Dec 2017 Jul-Sep 2017 Apr-Jun 2017 Jan-Mar 2017 Oct-Dec 2016 Jul-Sep 2016 Apr-Jun 2016 Jan-Mar 2016 Oct-Dec 2015
announcement
Conference/Earnings Calls Alerts
logo
Aurobindo Pharma Ltd.
25 Aug 2021
1043.90
0.36%
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Please refer to our letter dated August 7, 2021 wherein we have intimated the schedule of Investors/ Analysts call on August 13, 2021. We are attaching herewith the Transcript of the analyst / investor call on the Un-audited Financial Results of the Company for the first quarter ended June 30, 2021 and the same is being uploaded on the website of the Company and is available in the following web link. https://www.aurobindo.com/investors/results-reports-presentations/conference-call-transcripts/
pdf
logo
Aurobindo Pharma Ltd.
13 Aug 2021
1043.90
0.36%
Earnings Call for Q1FY22 of Aurobindo Pharma
Conference Call with Aurobindo Pharma Management and Analysts on Q1FY22 Performance and Outlook. Listen to the full earnings transcript.
video
 
logo
Aurobindo Pharma Ltd.
11 Jun 2021
1043.90
0.36%
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Please refer to our letter dated May 28, 2021 wherein we have intimated the schedule of Investors/ Analysts call on May 31, 2021. We are attaching herewith the Transcript of the analyst / investor call on the Audited Financial Results of the Company for the fourth quarter and year ended March 31, 2021 and the same is being uploaded on the website of the Company and is available in the following web link. https://www.aurobindo.com/investors/results-reports-presentations/conference-call-transcripts/
pdf
logo
Aurobindo Pharma Ltd.
31 May 2021
1043.90
0.36%
Earnings Call for Q4FY21 of Aurobindo Pharma
Conference Call with Aurobindo Pharma Management and Analysts on Q4FY21 Performance and Outlook. Listen to the full earnings transcript.
video
 
logo
Aurobindo Pharma Ltd.
25 Feb 2021
1043.90
0.36%
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Please refer to our letter dated February 9, 2021 wherein we have intimated the schedule of Investors/ Analysts call on February 11, 2021. We are attaching herewith the Transcript of the analyst / investor call on the Un-audited Financial Results of the Company for the third quarter and nine months period ended December 31, 2020 and the same is being uploaded on the website of the Company and is available in the following web link. https://www.aurobindo.com/investors/results-reports-presentations/conference-call-transcripts/
pdf
logo
Aurobindo Pharma Ltd.
27 Nov 2020
1043.90
0.36%
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Please refer to our letter dated November 10, 2020 wherein we have intimated the schedule of Investors/ Analysts call on November 12, 2020. We are attaching herewith the Transcript of the analyst / investor call on the Un-audited Financial Results of the Company for the second quarter and half year ended September 30, 2020 and the same is being uploaded on the website of the Company and is available in the following web link. https://www.aurobindo.com/investors/results-reports-presentations/conference-call-transcripts/
pdf
logo
Aurobindo Pharma Ltd.
12 Nov 2020
1043.90
0.36%
Earnings Call for Q2FY21 of Aurobindo Pharma
Conference Call with Aurobindo Pharma Ltd. Management and Analysts on Q2FY21 Performance and Outlook. Listen to the full earnings transcript.
video
 
logo
Aurobindo Pharma Ltd.
25 Aug 2020
1043.90
0.36%
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Please refer to our letter dated August 10, 2020 wherein we have intimated the schedule of Investors/Analysts call on August 13, 2020. We are attaching herewith the Transcript of the analyst / investor call on the Un-audited Financial Results of the Company for the first quarter ended June 30, 2020 and the same is being uploaded on the website of the Company and is available in the following web link. https://www.aurobindo.com/investors/results-reports-presentations/conference-call-transcripts/
pdf
logo
Aurobindo Pharma Ltd.
13 Aug 2020
1043.90
0.36%
Earnings Call Transcript - Q1FY21 for Aurobindo Pharma

Conference Call with Aurobindo Pharma Management and Analysts on Q1FY21 Performance and Outlook. Listen to the full earnings transcript. 

video
 
logo
Aurobindo Pharma Ltd.
18 Jun 2020
1043.90
0.36%
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Please refer to our letter dated June 1, 2020 wherein we have intimated the schedule of Investors/Analysts call on June 4, 2020. We are attaching herewith the Transcript of the analyst / investor call on the Audited Financial Results of the Company for the fourth quarter and year ended March 31, 2020 and the same is being uploaded on the website of the Company and is available in the following web link: https://www.aurobindo.com/investors/results-reports-presentations/conference-call-transcripts/
pdf

Earnings Calls Podcast on